Results 221 to 230 of about 153,225 (341)

Efficacy and safety of tozorakimab in moderate‐to‐severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER‐2)

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In FRONTIER‐2 (NCT04212169), a Phase 2a, randomized, placebo‐controlled study of 148 adults with moderate‐to‐severe atopic dermatitis, no statistically significant differences between tozorakimab and placebo were observed in the percentage change in EASI score from baseline to Week 16.
J. I. Silverberg   +13 more
wiley   +1 more source

Bacillus cereus is a key microbial determinant of intractable otitis media with effusion. [PDF]

open access: yesCommun Med (Lond)
Fan Y   +11 more
europepmc   +1 more source

Otitis Media in all Grave Diseases of Infancy [PDF]

open access: green, 1901
CHAELES H. BURNETT, E. Pomeroy
openalex   +1 more source

Otitis Media in Children with Severe Acute Malnutrition: A Scoping Review. [PDF]

open access: yesChildren (Basel)
Eslick CJ   +5 more
europepmc   +1 more source

Editorial: Otitis media

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Kevin M. Mason   +5 more
openaire   +3 more sources

<i>Pseudomonas aeruginosa</i> in Chronic Suppurative Otitis Media. [PDF]

open access: yesInfect Chemother
Artono A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy